Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Why index readings matter: they provide a concise pulse on market health, guiding timely adjustments to risk and allocation.
21,223 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A timely, original take on three durable compounders—Apple, Microsoft, and Coca-Cola—that have made patient investors...
Ford is aiming high with an AI-driven energy storage push. This article breaks down what that could mean for investor...
The U.K. moves to bar under-16s from major platforms, setting up a widening policy shift that could reshape families’...
A frightened call claimed a loved one was in trouble, pushing for quick payment. She paused, verified, and saved thou...
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
A widening gap between top earners and the middle class is shrinking Social Security's funding base, prompting renewe...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
A new bipartisan housing bill aims to curb investor hoarding and expand aid for first-time buyers. The measure would ...
A promising AI-driven play could redefine long-term portfolios. Learn why this stock might be a once-in-a-decade inve...
Pennymac confirms it will shutter its Franklin, TN office and reduce staff in its consumer direct lending unit, part ...
Adobe and Duolingo sit at opposite ends of the tech stock spectrum: one is a cash-generating powerhouse, the other a ...